MAPT and Alzheimer disease: In recent years, abnormalities in the metabolism of cholesterol, sphingolipids, glycerophospholipids, and phosphatidylinositol 4,5-bisphosphate (PIP2) have been shown to play an important role in AD development by promoting Aβ (NP) and tau (NFT) deposition [15,19].